Fa. Sehba et al., Effects of S-nitrosoglutathione on acute vasoconstriction and glutamate release after subarachnoid hemorrhage, STROKE, 30(9), 1999, pp. 1955-1961
Background and Purpose-Subarachnoid hemorrhage (SAH) causes acute vasoconst
riction that contributes to ischemic brain injury shortly after the initial
bleed. It has been theorized that decreased availability of nitric oxide (
NO) may contribute to acute vasoconstriction. Therefore we examined the eff
ect of the NO donor N-nitroso glutathione (GSNO) on acute vasoconstriction
and early ischemic glutamate release after experimental SAH.
Methods-SAH was induced by the endovascular suture method in anesthetized r
ats. GSNO (1 mu mol/L/kg, n = 31) or saline (n = 21) was injected 5 minutes
after SAH, Sham-operated rats received GSNO (1 mu mol/L/kg, n = 5) 5 minut
es after sham surgery. Arterial and intracranial pressures, cerebral blood
flow (CBF), and extracellular glutamate release were measured serially for
60 minutes after SAH, SAH size was determined, and vascular measurements we
re made histologically.
Results-GSNO had no effect on resting blood pressure, intracranial pressure
, cerebral perfusion pressure, or CBF in sham-operated animals. However, ad
ministration of GSNO after SAH was associated with significantly increased
CBF (161.6 +/- 26.6% versus saline 37.1 +/- 5.5%, 60 minutes after SAH, P<0
.05), increased blood vessel diameter (internal carotid artery [ICA] 285.0
+/- 16.5 mu m versus saline 149.2 +/- 14.1 mu m, P<0.01), decreased vessel
wall thickness (ICA12.9 +/- 0.7 mu m versus saline 25.1 +/- 1.6 mu m, P<0.0
1), and decreased extracellular glutamate levels (3315.6 +/- 1048.3% versus
saline 469.7 +/- 134.3%, P<0.05), Blood pressure decreased transiently, wh
ereas intracranial pressure, cerebral perfusion pressure, and SAH size were
not affected,
Conclusions-These results suggest that GSNO can reverse acute vasoconstrict
ion and prevent ischemic brain injury after SAH. This further implies that
acute vasoconstriction contributes significantly to ischemic brain injury a
fter SAH and is mediated in part by decreased availability of NO.